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Abstract
Background: Metabolic syndrome (MS) is a metabolic disorder associated with obesity, type-II diabetes, and “low
grade inflammation”, with the concomitant increased risk of cardiovascular events. Removal of the inflammatory
mediator signals is a promising strategy to protect against insulin resistance, obesity, and other problems
associated with MS such as cardiovascular disease. The aim of the present investigation was to determine the
“inflammatory and stress status” in an experimental model of MS, and to evaluate the effect of a program of
habitual exercise and the resulting training-induced adaptation to the effects of a single bout of acute exercise.
Methods: Obese Zucker rats (fa/fa) were used as the experimental model of MS, and lean Zucker rats (Fa/fa) were
used for reference values. The habitual exercise (performed by the obese rats) consisted of treadmill running: 5
days/week for 14 weeks, at 35 cm/s for 35 min in the last month. The acute exercise consisted of a single session
of 25-35 min at 35 cm/s. Circulating concentrations of IL-6 (a cytokine that regulates the inflammatory and
metabolic responses), CRP (a systemic inflammatory marker), and corticosterone (CTC) (the main glucocorticoid in
rats) were determined by ELISA, and that of noradrenaline (NA) was determined by HPLC. Glucose was determined
by standard methods.
Results: The genetically obese animals showed higher circulating levels of glucose, IL-6, PCR, and NA compared
with the control lean animals. The habitual exercise program increased the concentration of IL-6, PCR, NA, and
glucose, but decreased that of CTC. Acute exercise increased IL-6, CRP, and NA in the sedentary obese animals, but
not in the trained obese animals. CTC was increased after the acute exercise in the trained animals only.
Conclusion: Animals with MS present a dysregulation in the feedback mechanism between IL-6 and NA which can
contribute to the systemic low-grade inflammation and/or hyperglycaemia of MS. An inappropriate exercise
intensity can worsen this dysregulation, contributing to the metabolic, inflammatory, and stress disorders
associated with MS. Habitual exercise (i.e., training) induces a positive adaptation in the response to acute exercise.
Background
Metabolic syndrome (MS) is a metabolic disorder asso-
ciated with obesity, and involves risk factors for type-II
diabetes mellitus and arteriosclerosis, with the concomi-
tant increased risk of cardiovascular events [1-3]. Obe-
sity is associated with “low-grade inflammation” [4-6], a
term that is used to reflect increments in the systemic
concentration of tumour necrosis factor-alpha (TNF-a),
interleukin (IL)-1b, IL-6, IL-1ra, and C-reactive protein
(CRP) [7]. IL-6, CRP, and TNF-a are the main inflam-
matory molecules associated with obesity-related inflam-
mation. They are involved in the pathobiology of MS-
associated disorders, such as obesity, insulin resistance,
coronary heart disease, type-II diabetes, and hyperten-
sion [4,6,8-10]. Wellen and Hotamisligil (2005) proposed
a model of interaction between the metabolic and
immune systems. In this model, the relationship
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between obesity and inflammation appears to be two-way
and involves positive feedback, i.e., inflammation per se
induces obesity and insulin resistance, and in turn obesity
induces low-grade inflammation and promotes insulin
resistance and all of the other characteristics associated
with MS [6]. Inflammatory cytokines can also stimulate
the hypothalamus-pituitary-adrenal (HPA) axis, with, as a
consequence, increased levels of glucocorticoids affecting
inflammatory and immune processes. Disruption of the
cytokine-HPA axis feedback loop can aggravate inflam-
matory pathologies [11]. It is also well established that
noradrenaline (NA) is involved in regulating both meta-
bolism and most of the mechanisms of the immune
response, including the innate response and the systemic
and local release of inflammatory cytokines [12-16,11]
such as IL-6 [17,18]. Indeed, noradrenergic dysfunction,
including over-activity of the sympathetic nervous system
(SNS), is today also recognized as a characteristic of obe-
sity-related MS, contributing to the pathophysiology and
clinical prognosis [19,20].
Removal of the inflammatory mediator signals would
seem to be a promising strategy to protect against insu-
lin resistance, obesity, and the other problems associated
with MS, such as cardiovascular diseases [21-23,6]. Exer-
cise (with or without caloric restriction) has frequently
been recommended for obese persons [24]. Indeed,
habitual aerobic exercise is an accepted therapeutic
strategy in the management of MS since it improves the
diabetic status and insulin sensitivity, thus reducing the
risk of cardiovascular disease [25]. Based on its anti-
inflammatory effects [26], exercise can also be used as a
means to control low-grade systemic inflammation [27].
Nevertheless, it is also clearly accepted that exercise is a
form of stress, and that the relation between exercise,
stress, and inflammation is a good model of neuroendo-
crine interaction. Exercise stimulates the innate immune
responses, with its effects on the inflammatory response
in particular being mediated by activation of the SNS
and/or the HPA axis [28-30]. A well-controlled and
regulated stimulation of the innate and/or inflammatory
immune mechanisms during exercise can help prevent
infection, but over-stimulation of the inflammatory
response could also be harmful for people with inflam-
matory diseases [12,31,28,32,33], as might well be the
case in MS and cardiovascular-associated disorders.
The obese Zucker rat (fa/fa) is the most commonly
used animal model for the study of human type-II dia-
betes [34,35,10]. Given this context, the aim of the pre-
sent investigation was to determine the “inflammatory
and stress status” of obese Zucker rats compared to
healthy lean rats used as control, and to evaluate the
effect of a program of habitual exercise performed by
the obese rats in the form of training-induced adapta-
tion to the effects of a single session of acute exercise.
Methods
Animals and experimental design
45 male Zucker rats (Harlan, United Kingdom) were
used, comprising 36 obese rats (HsdOla:ZUCKER-Leprfa,
homozygous fa/fa) as the experimental model for the MS
study, and 9 lean rats (heterozygous Fa/fa) as the healthy
controls for reference values. Obese Zucker rats carry a
spontaneous obesity-causing mutation in the leptin
receptor gene (fa) (Leprfa is an autosomal recessive muta-
tion on chromosome 5). They exhibit obesity at 4 to 5
weeks of age (680 ± 5 g obese vs 421 ± 8 g lean rats
immediately before sacrifice at 6 months of age), and
share many metabolic characteristics with human obe-
sity-associated type-II diabetes such as insulin-resistance,
hyperphagia, hyperlipidaemia (developing adipocyte
hypertrophy and hyperplasia), hypercholesterolaemia,
muscle atrophy, and hyperinsulinaemia (as specified by
Harlam). At the beginning of the experiment, the rats
were 2 months old, and were housed in cages with food
(A04 diet, SAFE, France) and water ad libitum in the ani-
mal facilities of the Medical Faculty of the Autonomous
University of Madrid. The animals were undisturbed
until they were 10-12 weeks old. Then, the experimental
design was targeted at studying the differences between
the lean and obese rats, the effects of habitual exercise or
training on the obese rats, and the responses to a single
bout of acute exercise performed by the obese sedentary
or obese trained animals.
The obese Zucker rats (n = 36) were divided into 4
experimental groups: sedentary rats (n = 9), sedentary
rats that performed a single bout of acute exercise (n =
9), trained rats (n = 9), and trained rats that performed
a single bout of acute exercise (n = 9). All animals were
killed at approximately 6 months of age. Given that rats
are animals with nocturnal activity, the light/dark cycle
was adapted for the animals to perform exercise during
their active phase, with the onset of the dark phase
about 2 hours before the start of the training sessions
(light 01:30 - 13:30 h; dark 13:30-01:30 h). The animals
were trained habitually between 15:00 and 18:00 h. The
trained animals were kept at rest for 72 hours prior to
collection of blood or to the performance of the bout of
acute exercise. The blood samples following these bouts
of acute exercise were collected immediately at the con-
clusion of the session. Sedentary lean Zucker rats also 6
months old (n = 9) were used as controls to get refer-
ence values in healthy animals. At 08:30 on the day the
animals were killed, feed was withdrawn from all the
animals.
Blood samples were collected from anaesthetized ani-
mals. The circulating concentrations of IL-6, CRP, NA,
and corticosterone (CTC) were determined in each ani-
mal. The comparison of the results between the obese
and the lean Zucker rats revealed the differences in the
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inflammatory and stress biomarkers evaluated in this
experimental model of MS, and the comparison between
the different experimental groups of obese animals
revealed the immunophysiological adaptations and
responses to physical exercise.
Exercise
The habitual exercise training consisted of running on a
treadmill (Li 870, Letica Scientific Instruments, Barce-
lona, Spain) with no slope, based on adaptation, pro-
gression, and maintenance phases in intensity and
duration from 25 cm/s for 10 min in the first weeks to
values close to 35 cm/s for 35 min in the last month.
The exercise was performed 5 days per week, for 14
weeks. The bout of acute exercise consisted of running
on the treadmill for 5 min at 17 cm/s followed by 25-35
min at 35 cm/s, with no slope.
Ethical approval
The experiment was approved by the Ethical Commit-
tees of the Autonomous University (Madrid, Spain) and
of the University of Extremadura (Badajoz, Spain)
according to the “Principles of Laboratory Animal Care”
(NIH publication No. 86-23, revised 1985) and, the
guidelines of the European Community Council Direc-
tives and the Declaration of Helsinki.
Anaesthesia and collection of serum and plasma
The fasted animals were gas anaesthetized with isoflur-
ane (AErrane, Baxter, Valencia, Spain), with a starting
dose of 2% oxygen and 3.5% isoflurane, and mainte-
nance dose of 1.5% oxygen and 3% isoflurane. Blood
was extracted from the live animals, drawn from the
abdominal mesenteric vein using heparinized syringes.
One additional drop was taken for the direct estimation
of glycaemia using Accutrend strips (Roche). For the
serum isolation, the blood was deposited in tubes with-
out anticoagulant at room temperature for 30 min and
then centrifuged at 700 g for 10 min at room tempera-
ture. For the plasma isolation, the blood was deposited
in tubes with 0.1 volumes of cold anticoagulant (26 mM
of EGTA and 130 mM DTT) and centrifuged at 900 g
for 7 min.
Plasma noradrenaline determination
Plasma samples from each animal were stored at -80°C
until assay. Noradrenaline concentration was determined
by HPLC (Electrochemical Detection, Coulochem) using
a commercial kit (Chromosystems Instruments and
Chemical, GMBH, Munich, Germany). During the
extraction of the samples, an internal standard (dihy-
droxybenzylamine) was added to allow the subsequent
calculation of the exact original concentration avoiding
losses during the process. The column used was a C18
(Waters), the working potential was between 450 and
660 mV, the flow was 1 ml/min, and the pressure did
not exceed 200 bar. After injection of 20 μl of the final
processed sample, a chromatogram was obtained in
which one peak was observed at a lag of approximately
4 min, corresponding to noradrenaline.
Serum CRP, IL-6, and CTC determinations
Serum samples from each animal were stored at - 80°C
until assay. The CTC and CRP concentrations were
determined by a double polyclonal antibody sandwich
enzyme immunoassay (EIA) specific for rats (DRG
Instruments GmbH, Germany for CTC; Chemicon
International, USA for CRP), and IL-6 concentrations by
a solid-phase sandwich enzyme-linked immunosorbent
assay (ELISA) specific for rats (Biosource Immunoassay,
Nivelles, Belgium). Samples were assayed at optimal
concentrations and according to the manufacturer’s
instructions.
Statistical analysis
Values are given as mean ± SEM. The variables were
normally distributed (tested by the normality test). Stu-
dent’s t-test was used for comparisons between the pairs
of groups (non-paired samples). A non-parametric
ANOVA and Scheffe’s F-test was used for comparisons
among the three experimental groups. The minimum
significance level was taken to be p<0.05.
Results
The obese Zucker rats had higher circulating levels of
glucose (p<0.01, Figure 1), IL-6 (p<0.001 Figure 2), CRP
(p<0.001, Figure 3), and NA (p<0.001, Figure 4) than the
lean rats. There were no significant differences in the
circulating concentrations of CTC (Figure 5) probably
Figure 1 Circulating levels of glucose in obese Zucker rats:
effect of habitual exercise (control lean rats are used as
reference values). Each column represents the mean ± SEM of the
values obtained in 9 animals of each experimental group. ** p <
0.01, *** p < 0.001 lean vs obese rats; # p < 0.05 sedentary vs
trained obese rats.
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because of the high levels presented by the Zucker
strain in comparison with other rat strains (such as Wis-
tar, which in our laboratory present values of around 50
ng/ml). One also observes in these figures that the
obese animals which performed the habitual exercise
protocol for 14 weeks had higher circulating levels of
glucose (p<0.05, Figure 1), IL-6 (p<0.01 Figure 2), CRP
(p<0.01, Figure 3), and NA (p<0.001, Figure 4) than the
sedentary obese animals, but lower levels of CTC
(p<0.05, Figure 5).
Table 1 presents the effects of a bout of exercise on
the sedentary and trained obese rats. One observes that
the effect on the sedentary obese animals was to
increase their circulating levels of IL-6 (p<0.001), CRP
(p<0.05), and NA (p<0.01) relative to those which did
not perform this bout of exercise. But no such stimula-
tion of the three markers was observed in the trained
obese animals. Indeed, these animals showed a slight
(although not significant) decrease in the concentration
of these markers in response to the bout of exercise.
This difference between the trained and sedentary ani-
mals was especially notable in the case of IL-6, with a
decline to a value that was significantly lower (p<0.05)
than that of the sedentary animals which performed the
bout of acute exercise. This occurred in parallel with an
increase in the circulating concentration of CTC. There
were no significant changes in glucose levels in response
to the bout of exercise in either group of obese animals.
Discussion
Dysregulation in stress and inflammatory biomarkers in
MS
It is currently accepted that neuro-immuno-endocrine
disorders can play a role in obesity, hypertension, and
Figure 2 Circulating levels of IL-6 in obese Zucker rats: effect
of habitual exercise (control lean rats are used as reference
values). Each column represents the mean ± SEM of the values
obtained in 9 animals of each experimental group. *** p < 0.001
lean vs obese rats; ## p < 0.01 sedentary vs trained obese rats.
Figure 3 Circulating levels of CRP in obese Zucker rats: effect
of habitual exercise (control lean rats are used as reference
values). Each column represents the mean ± SEM of the values
obtained in 9 animals of each experimental group. *** p < 0.001
lean vs obese rats; ## p < 0.01 sedentary vs trained obese rats.
Figure 4 Circulating levels of NA in obese Zucker rats: effect of
habitual exercise (control lean rats are used as reference
values). Each column represents the mean ± SEM of the values
obtained in 9 animals of each experimental group. *** p < 0.001
lean vs obese rats; ###p < 0.001 sedentary vs trained obese rats.
Figure 5 Circulating levels of corticosterone in obese Zucker
rats: effect of habitual exercise (control lean rats are used as
reference values). Each column represents the mean ± SEM of the
values obtained in 9 animals of each experimental group. #p < 0.05
sedentary vs trained obese rats.
Martín-Cordero et al. Cardiovascular Diabetology 2011, 10:42
http://www.cardiab.com/content/10/1/42
Page 4 of 9
insulin resistance, and that neuro-immuno-endocrine
dysfunction is associated with abnormalities in the
inflammatory response or with the local over-activity of
pro-inflammatory factors [13]. The high systemic levels
of IL-6 and CRP in the obese animals of the present
study, together with the high concentration of IL-1b
also found in this animal model [35], confirm the low-
grade inflammation that occurs in MS [4-6,36]. Similar
results for CRP and IL-6 have been reported in the lit-
erature, also in Zucker diabetic rats [8,9]. In addition to
their “inflammatory status”, our obese animals presented
a state of hyperglycaemia and systemic stress manifest
in their higher concentrations of glucose and NA com-
pared with the lean rats used as controls. We found no
differences, however, in CTC concentrations, probably
because of the Zucker strain’s surprisingly high concen-
tration of this hormone (and of IL-6), which could indi-
cate that this strain has a dysregulated IL-6-CTC loop.
It has been reported that NA affects IL-6 release, in
both inhibition and activation [17,18]. Although a differ-
ent behaviour in pathological conditions such as MS
cannot be ruled out, in healthy individuals NA generally
causes decreases/increases in the systemic concentra-
tions of inflammatory/anti-inflammatory cytokines,
respectively [12,37]. Also IL-6, together with IL-1b, can
stimulate the HPA axis and the SNS, and therefore the
release of NA and glucocorticoids [38,11,12]. The stress
system activated by the immune system thus stimulates
a negative feedback mechanism that protects the organ-
ism from an excess of inflammatory proteins. Nonethe-
less, under conditions of stress and in pathological
inflammatory conditions, NA may induce a rise in the
systemic levels of IL-6 [39]. The high levels of NA and
IL-6 (and IL-1b [35]) found in obese animals may reflect
defective regulation of the negative inflammatory/stress
feedback loop in MS - a physiological state that may in
turn be either the cause or the consequence of the dia-
betes associated with obesity. Although the CTC levels
determined in this study do not allow us to clearly con-
clude that the inflammatory cytokine-HPA axis feedback
is dysregulated in obesity, the results do suggest reduced
responsiveness to high levels of IL-6 in corticosterone
release in the obese Zucker rats.
The multifunctional cytokine IL-6 is clearly involved
in the regulation of metabolism, with confirmation of
the link between obesity and inflammation [40-42].
Although IL-6 has traditionally been reported to play an
important role in the pathogenesis of coronary artery
disease and atherosclesoris, the possibility that IL-6 has
many beneficial effects on health has been put forward
recently. In this sense, IL-6 should not be considered
good or bad, but as a molecule with both beneficial
(particularly during exercise as discussed below) and
destructive effects [43]. The release of IL-6 into the sys-
temic circulation, and the fact that this release was
observed to be greater in the obese Zucker rats, lends
support to a recent suggestion that IL-6 plays a role as a
systemic regulator of body weight and lipid metabolism
[42]. There is still considerable controversy, however,
about the effects of raised systemic levels of IL-6. A few
years ago, this situation was linked to the development
of diabetes, hypertension, and hyperlipidaemia [40].
Thus, it has been suggested that circulating IL-6 plays
an important role in the development of insulin resis-
tance [44] and atherosclerosis through its effects on
metabolism: reducing hepatic insulin sensitivity and glu-
cose uptake by adipocytes, and causing raised plasma
insulin levels, hyperglycaemia, and hyperlipidaemia
(reviewed by Eder and co-workers [42]). Other studies
argue for IL-6 having a lipolytic role [45-47,27], with its
participation in lipolysis and fat oxidation [46,48]. The
controversy was sharpened with the observation that IL-
6 knock-out mice develop mature-onset obesity, with
hypertriglyceridaemia, glucose intolerance, and other
features of MS [45] and the contrary results of a subse-
quent study [49] which observed no such phenomenon,
probably because the comparison was made with differ-
ent control strains [42]. It is now known that the cellu-
lar response to IL-6 depends on the metabolic state of
the cell as well as on a combination of other external
stimuli [50,51]. Therefore, to help resolve this contro-
versy concerning the inflammatory (pro- or anti-
Table 1 Effect of acute exercise on metabolic, inflammatory, and stress biomarkers in the obese Zucker rats: Training-
induced adaptation.
Obese sedentary rats Obese trained rats
without acute exercise with acute exercise without acute exercise with acute exercise
Glucose (mg/dl) 314.4 ± 12 289.5 ± 15 357.5 ± 15 364.6 ± 17
NA (pg/ml) 186 ± 26 319 ± 47 ** 311 ± 29 283 ± 42
IL-6 (pg/ml) 76.5 ± 4.2 128 ± 14.7 *** 100 ± 6.2 88 ± 9.9 #
CRP (μg/ml) 338 ± 17 390 ± 9 * 430 ± 22 412 ± 19
Corticosterone 451 ± 13 468 ± 11 408 ± 33 478 ± 6●
Each number is the mean ± SEM of the values obtained in 9 animals of each experimental group. *p < 0.05, **p < 0.01, ***p < 0.001 obese sedentary rats
without acute exercise vs obese sedentary rats after acute exercise; #p < 0.05 vs obese sedentary rats after acute exercise; ●p < 0.05 vs obese trained rats
without acute exercise.
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inflammatory) and endocrine (whether or not inducive
of insulin resistance, and therefore hypo-or hyper-gly-
caemic) effects of IL-6 in MS, it is vital to clarify
whether inflammation is the cause or the consequence
of metabolic dysregulation. In view of the overall results
of the present study on the systemic levels of stress and
inflammation markers, in our opinion it would be most
plausible to hypothesize that elevated circulating levels
of IL-6 and NA are the origin (and a good marker) of
metabolic and “stress/neuroendocrine” inflammatory
dysregulation in MS. The elevation of IL-6 would induce
increased systemic release of NA (and probably of CTC
also), which in turn could stimulate (or at least not inhi-
bit) the release of IL-6 (or vice versa), and both NA and
IL-6 might stimulate the release of glucose into the
bloodstream. Elevated levels of IL-6 would also induce
an increased hepatic release of CRP, a manifestation
of pro-inflammatory status in MS. Therefore, this
experimental model of MS presents, in addition to a
hyperglycaemic state, a dysregulated inflammatory, neu-
roendocrine, and stress feedback system. Such dysregu-
lation has already been indicated as present in other
diseases of an inflammatory nature, with involvement of
the inflammatory cytokines, catecholamines, and gluco-
corticoids released through the activation of the SNS
and the HPA axis [12,39,11].
Effect of physical exercise on stress/inflammation
dysregulation in metabolic syndrome (MS)
Exercise is a form of physiological stress, and the rela-
tionship between it, stress, and inflammation is a good
model of neuroendocrine interaction. The effects of
exercise on the inflammatory response are primarily
mediated through the SNS and/or the HPA axis
[52,28-31]. Currently, regular physical activity is advo-
cated as an effective non-pharmacological form of inter-
vention in the treatment of several of the major
disorders of MS. It has been shown to improve dyslipi-
daemia, insulin sensitivity, and the immune response to
antigens [53-56,10]. It is therefore important to deter-
mine whether many of the benefits for MS attributed to
exercise may be partly explained by its effect on media-
tors of the inflammatory system and of stress, such as
the biomarkers studied in the present work. For exam-
ple, in obese Zucker rats, the beneficial effect of exercise
training on obesity and diabetes has been linked to anti-
inflammatory mechanisms, with improvements in the
circulating levels of CRP, adiponectin [8], IL-6, and
TNF-a [9]. This suggests that regular exercise reduces
systemic inflammation in MS, and that these inflamma-
tory benefits are also correlated with improvements in
several of the characteristics associated with MS. The
present results showed, however, that the obese rats per-
forming regular exercise have even higher circulating
levels of NA, IL-6, and CRP than the sedentary obese
rats.
During situations of exercise-induced stress (of parti-
cular importance in individuals with inflammatory
pathologies), NA stimulates the systemic IL-6 concen-
tration unrelated to inflammation [39]. Thus, the exer-
cise-induced increase in the systemic concentration of
IL-6 in the trained obese rats is probably noradrenaline
mediated. These rats’ elevated circulating levels of IL-6
could in turn stimulate a greater release of NA through
the activation of the SNS, and the two molecules
together (in a dysregulated interaction in MS) would
contribute to the observed higher glucose levels.
Another contribution to the higher concentration of IL-
6 in the trained obese rats could also come from their
lower concentration of CTC than in the sedentary obese
animals, partially reducing the inhibitory effect of gluco-
corticoids on the release of IL-6. Furthermore, the ele-
vated levels of IL-6 may also be contributing to
increasing the systemic levels of the inflammatory mar-
ker CRP in the trained obese animals, since IL-6 is one
of the most potent inducers of CRP release from the
liver [7] and it can also induce the release of CRP from
adipose tissue in MS [57]. The high concentration of
CRP in the trained animals of the present study suggests
that the exercise evaluated may in itself have a pro-
inflammatory rather than an anti-inflammatory effect.
The high glucose levels observed in the animals at the
end of the habitual exercise protocol may be associated
with the high levels of IL-6 and CRP. These, together
with the high levels of NA, could explain the lack of
improvement in insulin-resistance presented by these
MS animals, and may even contribute to exacerbating
this pathology and hence increase cardiovascular risks.
One must be cautious about using exercise in “inflam-
matory pathologies": if the intensity of the exercise were
inappropriate, instead of anti-inflammatory effects, it
might induce pro-inflammatory effects, with potentially
serious consequences in pathologies with an underlying
dysregulation of the inflammatory mechanisms, such as
is the case of MS as has been demonstrated by the
results of the present study.
The high levels of NA might be stimulating the innate
and/or inflammatory immune system, since it has been
postulated that the NA released during physical exercise
may act as a “stress mediator” or “danger signal” in
situations in which homoeostasis may be altered, stimu-
lating the innate and/or inflammatory immune
responses and thus being able to alert the organism to
possible attack by pathogens [58,28,30]. This would be
consistent with the improved anti-pathogen response
found in these animals after regular exercise [10,35].
Besedovsky & Del Rey (2007), in the very interesting
view they present of how the immune system functions,
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argue that, while immune responses are physiological
responses expected to be maximally efficient during
infectious/inflammatory diseases, they sometimes contri-
bute to pathology, since immunoregulation is itself a
physiological process that operates simultaneously and
interwoven with pathological events. Thus, one can con-
clude from the present results that the training protocol
used (suitable and accepted for healthy animals to
improve their innate immune response against patho-
gens) leads to a situation of stress and inflammation in
MS animals, manifest in their raised circulating levels of
NA, and that these could contribute (or vice versa) to
increasing the concentration of IL-6 and CRP that will
ultimately affect the regulation of glucose homoeostasis
in these obese animals.
Finally, prior regular exercise or training induced a
physiological adaptation in the obese animals to their
confrontation with a single bout of exercise, which
instead exacerbated the pro-inflammatory (increased
systemic concentration of CRP and IL-6) and stress
(increased systemic levels of NA) status of the sedentary
obese animals. Nevertheless, considering overall the
results for the trained animals, the decrease in NA and
increase in CTC concentrations would contribute to
reducing the systemic concentration of IL-6, and there-
fore also of CRP. Indeed, these results agree with the
idea that, during situations of exercise-induced stress,
catecholamines can stimulate IL-6 release and glucocor-
ticoids can inhibit it [33,39]. In addition, the results
overall showed that, for the MS animals, the single bout
of physical exercise only had an anti-inflammatory effect
in those that had been previously trained. Again, the key
could be IL-6, since its decline in levels may reduce the
release of NA and CRP, and allow a reduction in the
levels of CTC.
Conclusions
The animals with MS presented a dysregulation in the
negative feedback mechanism between IL-6 and NA
(and probably also CTC) that can contribute to the sys-
temic low-grade inflammation and/or hyperglycaemia of
MS. An inappropriate intensity of exercise can worsen
this dysregulation, increasing the levels of NA, IL-6, and
CRP, and contributing to the metabolic, inflammatory,
and stress disorders associated with MS. It appears to
be important to determine whether the origin of this
dysregulation is an increase in the release of IL-6 or NA
so as to understand the effects of regular physical
exercise.
Given its pleiotropic effects, regular physical activity or
training has been proposed as a “polypill” capable of
replacing, or at least reducing, the use of drugs to con-
trol the cardiovascular risks presented by obese type-II
diabetes patients [59]. In considering this suggestive
proposal, however, it needs to be emphasized that, as
would plainly be accepted for any “pharmacological
drug”, it is very important to individualize the “dose” of
the exercise treatment for each patient so as to avoid
the possible side effects of exercise such as unhealthy
pro-inflammatory and stress responses, since alterations
in the inflammatory-stress feedback loop can themselves
worsen MS.
Obviously, without ignoring the difficulty of extrapo-
lating directly to humans, our present study in obese
Zucker rats is a further warning for patients diagnosed
with diabetes/MS who frequently start exercise pro-
grams that might not be appropriate, thus increasing the
risk of deterioration of their condition due to increased
dysregulation of stress/inflammation feedback
mechanisms.
List of abbreviations
CRP: C-reactive protein; CTC: corticosterone; IL: interleukin; NA: noradrenaline;
MS: metabolic syndrome; HPA: hypothalamus-pituitary-adrenal; DM2: type-II
diabetes mellitus; SNS: sympathetic nervous system
Acknowledgements
This work was partially supported by grants from the Ministry of Science and
Innovation (DEP2006-56187-C04-03), Junta de Extremadura (GRU10020),
FEDER, RETICEF, and Fundacion Valhondo de Extremadura, Spain. We are
grateful for the collaboration of specialized personnel of the animal facilities
at the Faculty of Medicine of the Autonomous University of Madrid.
Authors’ contributions
All authors have read and approved the final version of the manuscript. LMC
performed the experimental work of the paper. These results form part of
her doctoral thesis (supervised by Dr Ortega). She also contributed to
writing the manuscript and the discussion of the results. JJG collaborated
actively in all the experimental work. MDH collaborated actively in all the
experimental work. EO is Director of the Immunophysiology Research group
to which all the authors belong. He designed the experiments, supervised
the experimental work, prepared the discussion of the results, and wrote the
main part of the manuscript. He is the principal investigator of the grants.
Competing interests
The authors declare that they have no competing interests.
Received: 22 March 2011 Accepted: 20 May 2011
Published: 20 May 2011
References
1. Hansen BC: The metabolic syndrome X. Ann N Y Acad Sci 1999, 892:1-24.
2. Eckel RH, Grundy SM, Zimmet PZ: The metabolic syndrome. Lancet 2005,
365:1415-1428.
3. Zimmet P, George K, Alberti MM, Serrano M: Una nueva definición
mundial del síndrome metabólico propuesta por la Federación
Internacional de Diabetes: fundamento y resultados. Rev Esp Cardiol 2005,
58:1371-1376.
4. Das UN: Is metabolic syndrome × an inflammatory condition? Exp Biol
Med 2002, 227:989-997.
5. Das UN: Metabolic syndrome X: an inflammatory condition? Curr
Hypertens Rep 2004, 6:66-73.
6. Wellen KE, Hotamisligil GS: Inflammation, stress, and diabetes. J Clin Invest
2005, 115:1111-1119.
7. Petersen AM, Pedersen BK: The anti-inflammatory effect of exercise. J Appl
Physiol 2005, 98:1154-1162.
8. De Lemos ET, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-Pereira P,
Silva AS, Teixeira F: Exercise training is associated with improved levels of
Martín-Cordero et al. Cardiovascular Diabetology 2011, 10:42
http://www.cardiab.com/content/10/1/42
Page 7 of 9
C-reactive protein and adiponectin in ZDF (type 2) diabetic rats. Med Sci
Monit 2007, 13:168-174.
9. Teixeira de Lemos E, Reis F, Baptista S, Pinto R, Sepodes B, Vala H, Rocha-
Pereira P, Correia da Silva G, Teixeira N, Silva AS, Carvalho L, Teixeira F,
Das UN: Exercise training decreases proinflammatory profile in Zucker
diabetic (type 2) fatty rats. Nutrition 2009, 25:330-339.
10. Martín-Cordero L, García JJ, Hinchado MD, Bote E, Manso R, Ortega E:
Habitual physical exercise improves macrophage IL-6 and TNF-α
deregulated release in the obese zucker rat model of the metabolic
syndrome. Neuroimmunomodulation 2011, 18:123-130.
11. Besedovsky HO, Del Rey A: Physiology of psychoneuroimmunology: A
personal view. Brain Behav Immun 2007, 21:34-44.
12. Elenkov IJ, Chrousos GP: Stress hormones, proinflammatory and anti-
inflammatory cytokines, and autoimmunity. Ann N Y Acad Sci 2002,
966:290-303.
13. Elenkov IJ, Iezzoni DG, Daly A, Harris AG, Chrousos GP: Cytokine
dysregulation, inflammation and well-being. Neuroimmunomodulation
2005, 12:255-269.
14. Ortega E, García JJ, Sáez MC, De la Fuente M: Changes with aging in the
modulation of macrophages by norepinephrine. Mech Ageing Dev 2000,
118:103-114.
15. García JJ, Sáez MC, De la Fuente M, Ortega E: Regulation of phagocytic
process of macrophages by noradrenaline and its end metabolito 4-
hydroxy-3-metoxyphenyl-glycol. Role of alpha- and beta-
adrenoreceptors. Mol Cell Biochem 2003, 254:299-304.
16. Sanders VM: Interdisciplinary research: Noradrenergic regulation of
adaptive immunity. Brain, Behaviour and Immunity 2006, 20:1-8.
17. Meltzer JC, MacNeil BJ, Sanders V, Pylypas S, Jansen AH, Greenberg AH,
Nance DM: Stress-induced suppression of in vivo splenic cytokine
production in the rat by neural and hormonal mechanisms. Brain Behav
Immun 2004, 18:262-273.
18. Nance DM, Sanders VM: Autonomic innervation and regulation of the
immune system (1987-2007). Brain Behav Immun 2007, 21:736-745.
19. Straznicky NE, Lambert EA, Nestel PJ, McGrane MT, Dawood T, Schlaich MP,
Masuo K, Eikelis N, de Courten B, Mariani JA, Esler MD, Socratous F,
Chopra R, Sari CI, Paul E, Lambert GW: Sympathetic neural adaptation to
hypocaloric diet with or without exercise training in obese metabolic
syndrome subjects. Diabetes 2010, 59:71-79.
20. Straznicky NE, Lambert GW, Lambert EA: Neuroadrenergic dysfunction in
obesity: an overview of the effects of weight loss. Curr Opin Lipidol 2010,
21:21-30.
21. Hirosumi J, Tuncman G, Chang L, Görgün CZ, Uysal KT, Maeda K, Karin M,
Hotamisligil GS: A central role for JNK in obesity and insulin resistance.
Nature 2002, 420:333-336.
22. Hotamisligil GS, Shargill NS, Spiegelman BM: Adipose expression of tumor
necrosis factor-alpha: direct role in obesity-linked insulin resistance.
Science 1993, 259:87-91.
23. Hotamisligil GS: Inflammation and metabolic disorders. Nature 2006,
444:860-867.
24. Pitsavos C, Panagiotakos DB, Chrysohoou C, Kavouras S, Stefanadis C: The
associations between physical activity, inflammation, and coagulation
markers, in people with metabolic syndrome: the ATTICA study. Eur J
Cardiovasc Prev Rehabil 2005, 12:151-158.
25. Bassuk SS, Manson JE: Epidemiological evidence for the role of physical
activity in reducing risk of type 2 diabetes and cardiovascular disease.
J Appl Physiol 2005, 99:1193-1204.
26. Pedersen BK: The anti-inflammatory effect of exercise: its role in diabetes
and cardiovascular disease control. Essays Biochem 2006, 42:105-117.
27. Mathur N, Pedersen BK: Exercise as a mean to control low-grade systemic
inflammation. Mediators Inflamm .
28. Ortega E: Neuroendocrine mediators in the modulation of phagocytosis
by exercise: physiological implications. Exerc Immunol Rev 2003, 9:70-94.
29. Ortega E, Giraldo E, Hinchado MD, Martínez M, Ibáñez S, Cidoncha A,
Collazos ME, García JJ: Role of Hsp72 and norepinephrine in the
moderate exercise-induced stimulation of neutrophils’ microbicide
capacity. Eur J Appl Physiol 2006, 98:250-255.
30. Ortega E, Giraldo E, Hinchado MD, Martín-Cordero L, García JJ: 72 kDa
extracellular heat shock protein (eHsp72), norepinephrine (NE), and the
innate immune response following moderate exercise. In Heat Shock
Proteins and Whole Body Physiology. Edited by: Asea A, Pedersen BK. USA:
Springer; 2010:329-350.
31. Ortega E: Physiological and biochemistry: influence of exercise on
phagocytosis. Int J Sports Med 1994, 15:5172-5178.
32. Medzhitov R: Origin and physiological roles of inflammation. Nature 2008,
454:428-435.
33. Giraldo E, Garcia JJ, Hinchado MD, Ortega E: Exercise intensity-dependent
changes in the inflammatory response in sedentary women: role of
neuroendocrine parameters in the neutrophil phagocytic process and
the pro-/anti-inflammatory cytokine balance. Neuroimmunomodulation
2009, 16:237-244.
34. Plotkin BJ, Paulson D, Chelich A, Jurak D, Cole J, Kasimos J, Burdick JR,
Casteel N: Immune responsiveness in a rat model for type II diabetes
(Zucker rat, fa/fa): susceptibility to Candida albicans infection and
leucocyte function. J Med Microbiol 1996, 44:277-283.
35. Martin-Cordero L, Garcia JJ, Giraldo E, De la Fuente M, Manso R, Ortega E:
Influence of exercise on the circulating levels and macrophage
production of IL-1beta and IFNgamma affected by metabolic syndrome:
an obese Zucker rat experimental animal model. Eur J Appl Physiol 2009,
107:535-543.
36. Wellen KE, Hotamisligil GS: Obesity-induced inflammatory changes in
adipose tissue. J Clin Invest 2003, 112:1785-1788.
37. Elenkov IJ: Neurohormonal-cytokine interactions: implications for
inflammation, common human diseases and well-being. Neurochem Int
2008, 52:40-51.
38. Besedovsky H, del Rey A, Sorkin E, Dinarello CA: Immunoregulatory
feedback between interleukin-1 and glucocorticoid hormones. Science
1986, 233:652-654.
39. Mastorakos G, Pavlatou M, Diamanti-Kandarakis E, Chrousos GP: Exercise
and the stress system. Hormones (Athens) 2005, 4:73-89.
40. Recasens M, Ricart W, Fernández-Real JM: Obesity and inflammation. Rev
Med Univ Navarra 2004, 48:49-54.
41. Steenberg A: The role of IL-6 in exercise-induced immune changes and
metabolism. Exerc Immunol Rev 2003, 9:40-47.
42. Eder K, Baffy N, Falus A, Fulop AK: The major inflammatory mediator
interleukin-6 and obesity. Inflamm Res 2009, 58:727-736.
43. Fisman EZ, Tenenbaum A: The ubiquitous interleukin-6: a time for
reappraisal. Cardiovasc Diabetol 2010, 9:62.
44. Bastard JP, Maachi M, Van Nhieu JT, Jardel C, Bruckert E, Grimaldi A,
Robert JJ, Capeau J, Hainque B: Adipose tissue IL-6 content correlates
with resistance to insulin activation of glucose uptake both in vivo and
in vitro. J Clin Endocrinol Metab 2002, 87:2084-2089.
45. Wallenius V, Wallenius K, Ahrén B, Rudling M, Carlsten H, Dickson SL,
Ohlsson C, Jansson JO: Interleukin-6-deficient mice develop matureonset
obesity. Nat Med 2002, 8:75-79.
46. Van Hall G, Steensberg A, Sacchetti M, Fischer C, Keller C, Schjerling P,
Hiscock N, Møller K, Saltin B, Febbraio MA, Pedersen BK: Interleukin-6
stimulates lipolysis and fat oxidation in humans. J Clin Endocrinol Metab
2003, 88:3005-3010.
47. Trujillo ME, Sullivan S, Harten I, Schneider SH, Greenberg AS, Fried SK:
Interleukin-6 regulates human adipose tissue lipid metabolism and
leptin production in vitro. J Clin Endocrinol Metab 2004, 89:5577-5582.
48. Petersen EW, Carey AL, Sacchetti M, Steinberg GR, Macaulay SL,
Febbraio MA, Pedersen BK: Acute IL-6 treatment increases fatty acid
turnover in elderly humans in vivo and in tissue culture in vitro. Am J
Physiol Endocrinol Metab 2005, 288:155-162.
49. Di Gregorio GB, Hensley L, Lu T, Ranganathan G, Kern PA: Lipid and
carbohydrate metabolism in mice with a targeted mutation in the IL-6
gene: absence of development of age related obesity. Am J Physiol
Endocrinol Metab 2004, 287:182-187.
50. Kamimura D, Ishihara K, Hirano T: IL-6 signal transduction and its
physiological roles: the signal orchestration model. Rev Physiol Biochem
Pharmacol 2003, 149:1-38.
51. Kristiansen OP, Mandrup-Poulsen T: Interleukin-6 and diabetes: the good,
the bad, or the indifferent? Diabetes 2005, 54(Suppl 2):114-124.
52. Barriga C, Martín MI, Ortega E, Rodriguez AB: Physiological concentrations
of melatonin and corticosterone in stress and their relationship with
phagocytic activity. J Neuroendocrinol 2002, 14:691-695.
53. Klimcakova E, Polak J, Moro C, Hejnova J, Majercik M, Viguerie N, Berlan M,
Langin D, Stich V: Dynamic strength training improves insulin sensitivity
without altering plasma levels and gene expression of adipokines in
subcutaneous adipose tissue in obese men. J Clin Endocrinol Metab 2006,
91:5107-5112.
Martín-Cordero et al. Cardiovascular Diabetology 2011, 10:42
http://www.cardiab.com/content/10/1/42
Page 8 of 9
54. Roberts CK, Barnard RJ: Effects of exercise and diet on chronic disease.
J Appl Physiol 2005, 98:3-30.
55. Roberts CK, Won D, Pruthi S, Kurtovic S, Sindhu RK, Vaziri ND, Barnard RJ:
Effect of a short-term diet and exercise intervention on oxidative stress,
inflammation, MMP-9, and monocyte chemotactic activity in men with
metabolic syndrome factors. J Appl Physiol 2006, 100:1657-1665.
56. Xiang L, Naik J, Hester RL: Exercise-induced increase in skeletal muscle
vasodilatory responses in obese Zucker rats. Am J Physiol Regul Integr
Comp Physiol 2005, 288:987-991.
57. Calabro P, Chang DW, Willerson JT, Yeh ET: Release of C-reactive protein
in response to inflammatory cytokines by human adipocytes: linking
obesity to vascular inflammation. J Am Coll Cardiol 2005, 46:1112-1113.
58. Ortega E, Giraldo E, Hinchado MD, Martín L, García JJ, De la Fuente M:
Neuroimmunomodulation during exercise: role of catecholamines as
“stress mediator” and/or “danger signal” for the innate immune
response. Neuroimmunomodulation 2007, 14:206-212.
59. Teixeira-Lemos E, Nunes S, Texeira F, Reis F: Regular physical exercise
training assists in preventing type 2 diabetes development: focus on its
antioxidant and anti-inflammatory properties. Cardiovasc Diabetol 2011,
10:12.
doi:10.1186/1475-2840-10-42
Cite this article as: Martín-Cordero et al.: The interleukin-6 and
noradrenaline mediated inflammation-stress feedback mechanism is
dysregulated in metabolic syndrome: Effect of exercise. Cardiovascular
Diabetology 2011 10:42.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Martín-Cordero et al. Cardiovascular Diabetology 2011, 10:42
http://www.cardiab.com/content/10/1/42
Page 9 of 9
